Sickle beta zero thalassemia and acute chest syndrome in pediatric: Case report

Authors

DOI:

https://doi.org/10.33448/rsd-v13i6.46016

Keywords:

Sickle cell trait; Hemoglobin S; Beta Thalassemia; Acute chest syndrome; Heterozygous.

Abstract

The objective of this article is to report the case of a 5-year-old male patient diagnosed with Sickle Beta Zero Thalassemia. An inherited disease that affects the hemoglobin of red blood cells, causing the formation of hemoglobin S (sickle cell) and thalassemia.  The presence of "zero" indicates the absence of normal hemoglobin in the blood. This condition leads to the sickle-shaped deformation of red blood cells, making their circulation in blood vessels difficult, generating complications, including acute chest syndrome. It is possible to recognize this rare disease by its clinical presentation and with the help of the laboratory. A diagnosis was established in the patient based on clinical findings such as diagnostic images, complete blood count, peripheral blood smear and hemoglobin electrophoresis and subsequent evaluation by the pediatric hematology specialist. Clinical genetics is increasingly relevant in today's medicine, and it is essential that primary care (PC) professionals become familiar with its concepts. The correct identification of these patients ensures adequate genetic counseling and the implementation of regular clinical controls. This allows for early preventive intervention and addressing health problems before they fully develop.

References

Alghamdi, F. A., Al-Kasim, F., Alshhada, F., Ghareeb, E., Azmet, F. R., Almudaibigh, A., & Alluqmani, R. (2024). Risk factors for acute chest syndrome among children with sickle cell anemia hospitalized for vaso-occlusive crises. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-023-48527-1

Bender, M. A., Carlberg, K., Adam, M. P., Feldman, J., & Mirzaa, G. M. (2003, 15 de septiembre, actualizado 2023, 28 de diciembre). Sickle cell disease. En M. P. Adam, H. H. Ardinger, R. A. Pagon, et al. (Eds.), GeneReviews [Internet]. University of Washington, Seattle.

Brandow, A. M., & Liem, R. I. (2022). Advances in the diagnosis and treatment of sickle cell disease. Journal of Hematology & Oncology, 15(1). https://doi.org/10.1186/s13045-022-01237-z

Cela, E., Beléndez, C., & Galarón, P. (2009). Interpretación de la electroforesis de hemoglobina. Anales de Pediatría Continuada, 7(3), 152–155. https://doi.org/10.1016/s1696-2818(09)71119-9

Dunlop, R., & Bennett, K. C. (2014). Pain management for sickle cell disease in children and adults. The Cochrane Library, 2019(6). https://doi.org/10.1002/14651858.cd003350.pub3

González-Pérez, C., Gómez-Carpintero García, A., & Cervera Bravo, Á. (2022). Influencia de la hidroxiurea en la gravedad de los episodios de síndrome torácico agudo en pacientes con drepanocitosis. Anales de Pediatría (Barcelona, Spain: 2003), 97(1), 63–65. https://doi.org/10.1016/j.anpedi.2021.08.006

Jameson, J. L., Loscalzo, J., Kasper, D. L., Longo, D. L., Fauci, A. S., & Hauser, S. L. (2022). Harrison principios de medicina interna (21a ed.). McGraw Hill.

Kirkham, J. K., Estepp, J. H., Weiss, M. J., & Rashkin, S. R. (2023). Genetic variation and sickle cell disease severity: A systematic review and meta-analysis. JAMA Network Open, 6(10), e2337484. https://doi.org/10.1001/jamanetworkopen.2023.37484

NCBI. (s/f). HBA2 hemoglobin subunit alpha 2 [Homo sapiens (human)] - Gene. Recuperado el 26 de mayo de 2024, de https://www.ncbi.nlm.nih.gov/gene/3040

NCBI. (s/f). HBB hemoglobin subunit beta [Homo sapiens (human)] - Gene. Recuperado el 26 de mayo de 2024, de https://www.ncbi.nlm.nih.gov/gene/3043

Nicklaus Children's Hospital. (s/f). Beta 0 talasemia drepanocítica. Recuperado el 26 de mayo de 2024, de https://www.nicklauschildrens.org/condiciones/beta-0-talasemia-drepanocitica

Panyasai, S., Fucharoen, G., & Fucharoen, S. (2015). Known and new hemoglobin A2 variants in Thailand and implication for β-thalassemia screening. Clinica Chimica Acta; International Journal of Clinical Chemistry, 438, 226–230. https://doi.org/10.1016/j.cca.2014.09.003

Rezende, P. V., Santos, M. V., Campos, G. F., Vieira, L. L. M., Souza, M. B., Belisário, A. R., & Viana, M. B. (2018). Clinical and hematological profile in a newborn cohort with hemoglobin SC. Jornal de Pediatria, 94(6), 666–672. https://doi.org/10.1016/j.jped.2017.09.010

Sans-Sabrafen, J. (2006). Hematología clínica (5a ed.). Elsevier.

Secretaría de la Organización Mundial de la Salud. (s/f). Talasemia y otras hemoglobinopatías. Recuperado el 26 de mayo de 2024, de https://apps.who.int/gb/ebwha/pdf_files/EB118/B118_5-sp.pdf

TBH Creative. (s/f). Acute chest syndrome. Recuperado el 26 de mayo de 2024, de https://www.ihtc.org/acute-chest-syndrome

Vacca, V. M., Jr, & Blank, L. (2017). Drepanocitosis: situación actual y perspectivas. Nursing, 34(6), 32–39. https://doi.org/10.1016/j.nursi.2017.11.010

Valiente, M. R. (s/f). Síndrome torácico agudo en niño con drepanocitosis. Revista Electrónica de Portalesmedicos.com. Recuperado el 26 de mayo de 2024, de https://www.portalesmedicos.com/publicaciones/articles/2224/1/Sindrome-toracico-agudo-en-nino-con-drepanocitosis.html

Wahed, A., Quesada, A., & Dasgupta, A. (2020). Hemoglobinopathies and thalassemias. En Hematology and Coagulation. Elsevier.

Ware, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017). Sickle cell disease. Lancet, 390(10091), 311–323. https://doi.org/10.1016/s0140-6736(17)30193

Published

03/06/2024

How to Cite

LÓPEZ MUÑOZ, D. F. .; GRISALES DOMÍNGUEZ, J. E.; DELGADO GARCÉS, N. .; LLANOS POSSO, V.; ARELLANO GENOY, C. .; ORTIZ CORRALES , O. P. . Sickle beta zero thalassemia and acute chest syndrome in pediatric: Case report. Research, Society and Development, [S. l.], v. 13, n. 6, p. e1113646016, 2024. DOI: 10.33448/rsd-v13i6.46016. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/46016. Acesso em: 12 oct. 2024.

Issue

Section

Health Sciences